Title:
MULTIPLE PPI DOSAGE FORM
Document Type and Number:
WIPO Patent Application WO2006009602
Kind Code:
A3
Abstract:
Herein provided are dosage forms (variously referred to as "formulations") comprising a PPI that is released from the dosage form as a first and a second dose. Each dose of PPI is present in an amount sufficient to raise the plasma levels of the PPI to at least 100 ng/ml.
Inventors:
TANEJA RAJNEESH (US)
VAKILYNEJAD MAJID (US)
VAKILYNEJAD MAJID (US)
Application Number:
PCT/US2005/019028
Publication Date:
August 31, 2006
Filing Date:
June 01, 2005
Export Citation:
Assignee:
TAP PHARMACEUTICAL PROD INC (US)
TANEJA RAJNEESH (US)
VAKILYNEJAD MAJID (US)
TANEJA RAJNEESH (US)
VAKILYNEJAD MAJID (US)
International Classes:
A61K31/4439
Domestic Patent References:
| WO1999032093A1 | 1999-07-01 |
Foreign References:
| EP1607088A1 | 2005-12-21 |
Other References:
SHARMA V K ET AL: "ORAL PHARMACOKINETICS OF OMEPRAZOLE AND LANSOPRAZOLE AFTER SINGLE AND REPEATED DOSES AS INTACT CAPSULES OR AS SUSPENSIONS IN SODIUM BICARBONATE", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, BLACKWELL SCIENTIFIC PUBLICATIONS LTD., CAMBRIDGE, GB, vol. 14, no. 7, 2000, pages 887 - 892, XP001181327, ISSN: 0269-2813
See also references of EP 1768668A2
See also references of EP 1768668A2
Download PDF:
Previous Patent: COMMUNICATIONS SYSTEM INCLUDING PHASED ARRAY ANTENNA PROVIDING NULLING AND RELATED METHODS
Next Patent: VEHICULAR CLEANING CONCENTRATE
Next Patent: VEHICULAR CLEANING CONCENTRATE